Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104


Effectiveness of Tocilizumab in Patients With Rheumatoid Arthritis is Unaffected by Comorbidity Burden or Obesity: Data From a US Registry.

Pappas DA, Etzel CJ, Crabtree M, Blachley T, Best J, Zlotnick S, Kremer JM.

J Rheumatol. 2020 Jan 15. pii: jrheum.190282. doi: 10.3899/jrheum.190282. [Epub ahead of print]


Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor.

Farutin V, Prod'homme T, McConnell K, Washburn N, Halvey P, Etzel CJ, Guess J, Duffner J, Getchell K, Meccariello R, Gutierrez B, Honan C, Zhao G, Cilfone NA, Gunay NS, Hillson JL, DeLuca DS, Saunders KC, Pappas DA, Greenberg JD, Kremer JM, Manning AM, Ling LE, Capila I.

Arthritis Res Ther. 2019 Oct 23;21(1):216. doi: 10.1186/s13075-019-1999-3.


Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting.

Mease PJ, Accortt NA, Rebello S, Etzel CJ, Harrison RW, Aras GA, Gharaibeh MMF, Greenberg JD, Collier DH.

Rheumatol Int. 2019 Sep;39(9):1547-1558. doi: 10.1007/s00296-019-04345-1. Epub 2019 Jul 18.


Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry.

Mease PJ, Etzel CJ, Huster WJ, Muram TM, Armstrong AW, Lisse JR, Rebello S, Dodge R, Murage MJ, Greenberg JD, Malatestinic WN.

RMD Open. 2019 May 24;5(1):e000867. doi: 10.1136/rmdopen-2018-000867. eCollection 2019.


Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice.

Pappas DA, Etzel CJ, Zlotnick S, Best J, Blachley T, Kremer JM.

Rheumatol Ther. 2019 Sep;6(3):421-433. doi: 10.1007/s40744-019-0162-6. Epub 2019 Jun 25.


Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry.

Mease PJ, Palmer JB, Hur P, Strober BE, Lebwohl M, Karki C, Reed GW, Etzel CJ, Greenberg JD, Helliwell PS.

J Eur Acad Dermatol Venereol. 2019 May;33(5):886-892. doi: 10.1111/jdv.15443. Epub 2019 Mar 5.


Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation.

Ljung L, Ueda P, Liao KP, Greenberg JD, Etzel CJ, Solomon DH, Askling J.

RMD Open. 2018 Dec 16;4(2):e000771. doi: 10.1136/rmdopen-2018-000771. eCollection 2018.


Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis.

Curtis JR, Flake DD, Weinblatt ME, Shadick NA, Østergaard M, Hetland ML, Brahe CH, Hwang YG, Furst DE, Strand V, Etzel CJ, Pappas DA, Wang X, Hwang CC, Sasso EH, Gutin A, Hitraya E, Lanchbury JS.

Rheumatology (Oxford). 2019 May 1;58(5):874-883. doi: 10.1093/rheumatology/key367.


Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study.

Kim K, Chung TH, Etzel CJ, Kim J, Ryu H, Kim DW, Hwu P, Hwu WJ, Patel SP, Liu M, Kim KB.

Cancer Epidemiol. 2018 Dec;57:80-84. doi: 10.1016/j.canep.2018.10.003. Epub 2018 Oct 19.


The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants.

El-Zein RA, Etzel CJ, Munden RF.

Transl Lung Cancer Res. 2018 Jun;7(3):336-346. doi: 10.21037/tlcr.2018.05.09.


Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis.

Kavanaugh A, Singh R, Karki C, Etzel CJ, Kremer JM, Greenberg JD, Griffith J.

Clin Rheumatol. 2018 Aug;37(8):2275-2280. doi: 10.1007/s10067-018-4140-0. Epub 2018 Jun 4.


Chronic obstructive pulmonary disease among lung cancer-free smokers: The importance of healthy controls.

Karpman MD, Eldridge R, Follis JL, Etzel CJ, Shete S, El-Zein RA.

Respir Investig. 2018 Jan;56(1):28-33. doi: 10.1016/j.resinv.2017.11.002. Epub 2017 Dec 6.


Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity.

Harrold LR, Stolshek BS, Rebello S, Collier DH, Mutebi A, Wade SW, Malley W, Greenberg JD, Etzel CJ.

J Rheumatol. 2018 Jan;45(1):78-82. doi: 10.3899/jrheum.161567. Epub 2017 Oct 1.


Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry.

Mease PJ, Karki C, Palmer JB, Etzel CJ, Kavanaugh A, Ritchlin CT, Malley W, Herrera V, Tran M, Greenberg JD.

J Rheumatol. 2017 Aug;44(8):1151-1158. doi: 10.3899/jrheum.160963. Epub 2017 Jun 15.


Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.

Mease PJ, Karki C, Palmer JB, Etzel CJ, Kavanaugh A, Ritchlin CT, Malley W, Herrera V, Tran M, Greenberg JD.

Arthritis Care Res (Hoboken). 2017 Nov;69(11):1692-1699. doi: 10.1002/acr.23249.


Sex differences in gout characteristics: tailoring care for women and men.

Harrold LR, Etzel CJ, Gibofsky A, Kremer JM, Pillinger MH, Saag KG, Schlesinger N, Terkeltaub R, Cox V, Greenberg JD.

BMC Musculoskelet Disord. 2017 Mar 14;18(1):108. doi: 10.1186/s12891-017-1465-9.


Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry.

Harrold LR, Stolshek BS, Rebello S, Collier DH, Mutebi A, Wade SW, Malley W, Greenberg JD, Etzel CJ.

Clin Rheumatol. 2017 Apr;36(4):895-901. doi: 10.1007/s10067-017-3593-x. Epub 2017 Mar 7.


Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritis.

Huynh DH, Boyd TA, Etzel CJ, Cox V, Kremer J, Mease P, Kavanaugh A.

RMD Open. 2017 Jan 16;3(1):e000395. doi: 10.1136/rmdopen-2016-000395. eCollection 2017.


Gout Prophylaxis Evaluated According to the 2012 American College of Rheumatology Guidelines: Analysis from the CORRONA Gout Registry.

Schlesinger N, Etzel CJ, Greenberg J, Kremer J, Harrold LR.

J Rheumatol. 2016 May;43(5):924-30. doi: 10.3899/jrheum.150345. Epub 2016 Mar 15.


Reply: To PMID 25989470.

Solomon DH, Greenberg J, Kremer JM, Etzel CJ.

Arthritis Rheumatol. 2015 Dec;67(12):3327-8. doi: 10.1002/art.39413. No abstract available.


Genome-wide Gene-Asbestos Exposure Interaction Association Study Identifies a Common Susceptibility Variant on 22q13.31 Associated with Lung Cancer Risk.

Liu CY, Stücker I, Chen C, Goodman G, McHugh MK, D'Amelio AM Jr, Etzel CJ, Li S, Lin X, Christiani DC.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1564-73. doi: 10.1158/1055-9965.EPI-15-0021. Epub 2015 Jul 21.


Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.

Solomon DH, Greenberg J, Curtis JR, Liu M, Farkouh ME, Tsao P, Kremer JM, Etzel CJ.

Arthritis Rheumatol. 2015 May;67(8):1995-2003. doi: 10.1002/art.39195. Erratum in: Arthritis Rheumatol. 2016 Feb;68(2):515.


Genetic Modulation of Neurocognitive Function in Glioma Patients.

Liu Y, Zhou R, Sulman EP, Scheurer ME, Boehling N, Armstrong GN, Tsavachidis S, Liang FW, Etzel CJ, Conrad CA, Gilbert MR, Armstrong TS, Bondy ML, Wefel JS.

Clin Cancer Res. 2015 Jul 15;21(14):3340-6. doi: 10.1158/1078-0432.CCR-15-0168. Epub 2015 Apr 22.


Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry.

Kavanaugh A, Lee SJ, Curtis JR, Greenberg JD, Kremer JM, Soto L, Etzel CJ, Cox V, Yoshida K, Reed GW, Solomon DH.

Ann Rheum Dis. 2015 Jun;74(6):1150-5. doi: 10.1136/annrheumdis-2014-206435. Epub 2014 Dec 3.


The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model.

El-Zein RA, Lopez MS, D'Amelio AM Jr, Liu M, Munden RF, Christiani D, Su L, Tejera-Alveraz P, Zhai R, Spitz MR, Etzel CJ.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2462-70. doi: 10.1158/1055-9965.EPI-14-0462. Epub 2014 Aug 29.


Suppression of Akt-mTOR pathway-a novel component of oncogene induced DNA damage response barrier in breast tumorigenesis.

Bhardwaj A, Rosen D, Liu M, Liu Y, Hao Q, Ganesan N, Etzel CJ, Gullett A, Albarracin CT, Bedrosian I.

PLoS One. 2014 May 8;9(5):e97076. doi: 10.1371/journal.pone.0097076. eCollection 2014.


Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes.

Rich TA, Liu M, Etzel CJ, Bannon SA, Mork ME, Ready K, Saraiya DS, Grubbs EG, Perrier ND, Lu KH, Arun BK, Woodard TL, Schover LR, Litton JK.

Fam Cancer. 2014 Jun;13(2):291-9. doi: 10.1007/s10689-013-9685-0.


Associations of menthol use with motivation and confidence to quit smoking.

Reitzel LR, Etzel CJ, Cao Y, Okuyemi KS, Ahluwalia JS.

Am J Health Behav. 2013 Sep;37(5):629-34. doi: 10.5993/AJHB.37.5.6.


Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.

Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E, Soliman KM, Li D.

Mol Carcinog. 2013 Nov;52 Suppl 1:E139-47. doi: 10.1002/mc.22057. Epub 2013 Jun 15.


Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study.

McHugh MK, Lopez MS, Ho CH, Spitz MR, Etzel CJ, El-Zein RA.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):135-45. doi: 10.1158/1055-9965.EPI-12-0435. Epub 2012 Nov 29.


Using haplotype analysis to elucidate significant associations between genes and Hodgkin lymphoma.

D'Amelio AM Jr, Monroy C, El-Zein R, Etzel CJ.

Leuk Res. 2012 Nov;36(11):1359-64. doi: 10.1016/j.leukres.2012.07.014. Epub 2012 Aug 14.


Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans.

McHugh MK, Schabath MB, Ho CH, Liu M, D'Amelio AM Jr, Greisinger AJ, Delclos GL, Spitz MR, Etzel CJ.

J Immigr Minor Health. 2013 Oct;15(5):910-7. doi: 10.1007/s10903-012-9690-7.


Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma.

Howell RM, Giebeler A, Koontz-Raisig W, Mahajan A, Etzel CJ, D'Amelio AM Jr, Homann KL, Newhauser WD.

Radiat Oncol. 2012 Jul 24;7:116. doi: 10.1186/1748-717X-7-116.


Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke.

Spitz MR, Gorlov IP, Amos CI, Dong Q, Chen W, Etzel CJ, Gorlova OY, Chang DW, Pu X, Zhang D, Wang L, Cunningham JM, Yang P, Wu X.

Cancer Discov. 2011 Oct;1(5):420-9. doi: 10.1158/2159-8290.CD-11-0080. Epub 2011 Aug 25.


Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention.

Hildebrandt MA, Lippman SM, Etzel CJ, Kim E, Lee JJ, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X.

Clin Cancer Res. 2012 Jul 1;18(13):3705-13. doi: 10.1158/1078-0432.CCR-11-3271. Epub 2012 May 10.


Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers.

Spitz MR, Gorlov IP, Dong Q, Wu X, Chen W, Chang DW, Etzel CJ, Caporaso NE, Zhao Y, Christiani DC, Brennan P, Albanes D, Shi J, Thun M, Landi MT, Amos CI.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1213-21. doi: 10.1158/1055-9965.EPI-12-0352-T. Epub 2012 May 9.


Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk.

El-Zein RA, Young RP, Hopkins RJ, Etzel CJ.

Cancer Prev Res (Phila). 2012 Apr;5(4):522-7. doi: 10.1158/1940-6207.CAPR-12-0042. Review.


Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium.

Coté ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, Spitz MR, Muscat JE, Rennert G, Aben KK, Andrew AS, Bencko V, Bickeböller H, Boffetta P, Brennan P, Brenner H, Duell EJ, Fabianova E, Field JK, Foretova L, Friis S, Harris CC, Holcatova I, Hong YC, Isla D, Janout V, Kiemeney LA, Kiyohara C, Lan Q, Lazarus P, Lissowska J, Le Marchand L, Mates D, Matsuo K, Mayordomo JI, McLaughlin JR, Morgenstern H, Müeller H, Orlow I, Park BJ, Pinchev M, Raji OY, Rennert HS, Rudnai P, Seow A, Stucker I, Szeszenia-Dabrowska N, Dawn Teare M, Tjønnelan A, Ugolini D, van der Heijden HF, Wichmann E, Wiencke JK, Woll PJ, Yang P, Zaridze D, Zhang ZF, Etzel CJ, Hung RJ.

Eur J Cancer. 2012 Sep;48(13):1957-68. doi: 10.1016/j.ejca.2012.01.038. Epub 2012 Mar 19.


Cigarette experimentation in Mexican origin youth: psychosocial and genetic determinants.

Wilkinson AV, Bondy ML, Wu X, Wang J, Dong Q, D'Amelio AM Jr, Prokhorov AV, Pu X, Yu RK, Etzel CJ, Shete S, Spitz MR.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):228-38. doi: 10.1158/1055-9965.EPI-11-0456. Epub 2011 Oct 25.


A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor.

Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, Wefel JS.

J Neurooncol. 2012 Mar;107(1):165-74. doi: 10.1007/s11060-011-0723-1. Epub 2011 Oct 2.


Earlier age of onset of BRCA mutation-related cancers in subsequent generations.

Litton JK, Ready K, Chen H, Gutierrez-Barrera A, Etzel CJ, Meric-Bernstam F, Gonzalez-Angulo AM, Le-Petross H, Lu K, Hortobagyi GN, Arun BK.

Cancer. 2012 Jan 15;118(2):321-5. doi: 10.1002/cncr.26284. Epub 2011 Sep 12. Erratum in: Cancer. 2012 Jun 1;118(11):2997.


A novel approach to exploring potential interactions among single-nucleotide polymorphisms of inflammation genes in gliomagenesis: an exploratory case-only study.

Amirian ES, Scheurer ME, Liu Y, D'Amelio AM Jr, Houlston RS, Etzel CJ, Shete S, Swerdlow AJ, Schoemaker MJ, McKinney PA, Fleming SJ, Muir KR, Lophatananon A, Bondy ML.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1683-1689. doi: 10.1158/1055-9965.EPI-11-0203. Epub 2011 Jul 1.


Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy.

Kamdar KY, Krull KR, El-Zein RA, Brouwers P, Potter BS, Harris LL, Holm S, Dreyer Z, Scaglia F, Etzel CJ, Bondy M, Okcu MF.

Pediatr Blood Cancer. 2011 Sep;57(3):454-60. doi: 10.1002/pbc.23162. Epub 2011 May 25.


Estimating individual risk for lung cancer.

Etzel CJ, Bach PB.

Semin Respir Crit Care Med. 2011 Feb;32(1):3-9. doi: 10.1055/s-0031-1272864. Epub 2011 Apr 15.


Hodgkin lymphoma risk: role of genetic polymorphisms and gene-gene interactions in DNA repair pathways.

Monroy CM, Cortes AC, Lopez M, Rourke E, Etzel CJ, Younes A, Strom SS, El-Zein R.

Mol Carcinog. 2011 Nov;50(11):825-34. doi: 10.1002/mc.20747. Epub 2011 Mar 3.


Policy implications of early onset breast cancer among Mexican-origin women.

Miranda PY, Wilkinson AV, Etzel CJ, Zhou R, Jones LA, Thompson P, Bondy ML.

Cancer. 2011 Jan 15;117(2):390-7. Erratum in: Cancer. 2011 Feb 15;117(4):878.


Cytokinesis-blocked micronucleus assay and cancer risk assessment.

El-Zein R, Vral A, Etzel CJ.

Mutagenesis. 2011 Jan;26(1):101-6. doi: 10.1093/mutage/geq071. Review.


Evaluating a New Risk Marker's Predictive Contribution in Survival Models.

Liu M, Kapadia AS, Etzel CJ.

J Stat Theory Pract. 2010 Dec 1;4(4):845-855.


The advantage of imputation of missing income data to evaluate the association between income and self-reported health status (SRH) in a Mexican American cohort study.

Ryder AB, Wilkinson AV, McHugh MK, Saunders K, Kachroo S, D'Amelio A Jr, Bondy M, Etzel CJ.

J Immigr Minor Health. 2011 Dec;13(6):1099-109. doi: 10.1007/s10903-010-9415-8.


Hodgkin disease risk: role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes.

Monroy CM, Cortes AC, Lopez MS, D'Amelio AM Jr, Etzel CJ, Younes A, Strom SS, El-Zein RA.

Mol Carcinog. 2011 Jan;50(1):36-46. doi: 10.1002/mc.20688.


Supplemental Content

Loading ...
Support Center